Looking forward to seeing our #pharma and academia #oncology collaborators at #asco23 - come by and say hello! lnkd.in/esB9QDgb

Learn the latest on the recent emergence of new imaging agents for evaluation of immuno-oncology treatment response and novel imaging metrics for annotating efficacy from Invicro’s Sean Carlin, PhD: bit.ly/3oGU8RI

Come chat with us out #snmmi2023 about your #neuroscience and #oncology questions. We are the leading #imaging #cro in #radiopharmaceuticals #drugdevelopment lnkd.in/eH4tFufR

#therapeutic #psychedelics lnkd.in/eZGQgiY9

#alzheimersdisease lnkd.in/e_BvyjaA

Come see us at #snmmi2023

We know the ins and outs of #radiopharmaceuticals and #nuclearmedicine - come chat with us at the booth or some to our annual shindig. #snmmi #snmmi2023 lnkd.in/ehyqKU-E

Watch experts from Novartis, Fusion Pharmaceuticals, RayzeBio & Invicro weigh in on the emerging field of #theranostics & the unique requirements for developing these therapies: bit.ly/3OLOTKU #radiopharmaceuticals #oncology #radioligandtherapy #imagingCRO

Radiochemistry support for alpha, beta & gamma emitting isotopes is one of the most crucial steps in developing & validating #radiopharmaceutical candidates. Discover our preclinical radiochemistry solutions: bit.ly/3KoJKWr #theranostics #radioligandtherapy

There’s been a lot of excitement with the launch of REALM Pharma Services (RPS). Stay tuned as we show you how #REALM brings together Genomics, Imaging, Pathology and Informatics for the next phase of #precisionmedicine! #integrateddiagnostics #pharmaservices #Ambry #Invicro

Discover our complete solutions including radiochemistry, preclinical research, dosimetry, clinical imaging core lab, image analysis and more: bit.ly/3EkTFsw #radiopharmaceuticals #theranostics #oncology #radioligandtherapy #imagingCRO

Congrats to our New Haven team for stepping it up - surpassing fundraising goals and braving the weather at the Walk to End Alzheimer’s. It’s not too late to join our Boston walk team on Oct. 15: bit.ly/46nGPWI

I am pro-Palestinian. Some might be surprised by this due to my recent advocacy on X for Israel, but you shouldn’t be. I am anti-terrorist, not anti-Palestinian. It is not inconsistent to be pro-Israel and pro-Palestinian. And my pro-Palestinian viewpoint is not a new one. My

I will always deliver results. The resignation of Harvard’s antisemitic plagiarist president is long overdue. Claudine Gay’s morally bankrupt answers to my questions made history as the most viewed Congressional testimony in the history of the U.S. Congress. Her answers were

Join Beth Rodriguez tomorrow, February 13, at #SCOPE2024 for a lunch session that promises to reshape your approach to late-phase CNS and Oncology imaging trials, from unraveling imaging CROs to navigating processes for start-ups. #SCOPEsummit #imagingCRO

JNM Illustrated Post: First-in-human ²¹²Pb-PSMA–targeted α-therapy SPECT/CT imaging in a patient with metastatic castration-resistant prostate cancer. ow.ly/1kt750QMSCL #NuclearMedicine #RPTherapy #ProstateCancer Dave Pattison AdvanCell Isotopes

Meet Dr. Kelly Henry , our dedicated leader whose passion for fostering the next generation of scientists shines brightly. Kelly's unwavering commitment to supporting junior women in science and her invaluable contributions to the field make her a beacon of inspiration 🌟

⁶⁸Ga-FAPI46 PET has potential as an effective imaging method for evaluating FAP expression in progressive fibrosis by #hypertension. ow.ly/fSyo50TxxjJ #NuclearMedicine #PETscan

Help accelerate the cure and submit your abstract by January 13, 2025 at 11:59pm for a chance to present your innovative scientific investigations to a global audience of medical imaging professionals at the 2025 SNMMI Annual Meeting in New Orleans! snmmi.org/AM/AM/Abstract…

Current capabilities and future prospects for dosimetry software for #theranostic applications: ow.ly/v0GV50UFJPl #NuclearMedicine #RPTherapy Julia Brosch-Lenz